Top Markets
#1 GoPlus Security GoPlus Security +31.58%
#2 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +18.85%
#3 Tutorial Tutorial +18.60%
#4 Status Status +15.77%
#5 Pons Pons +14.32%
#6 Wrapped NXM Wrapped NXM +14.12%
#7 Verus Coin Verus Coin +12.97%
#8 o1.exchange o1.exchange +10.06%
#9 SkyAI SkyAI +9.28%
#10 DMT-NAT DMT-NAT +8.92%
Coin of the day
GoPlus Security GoPlus Security
Einstellungen
Sprache
DEUTSCH
Währung
USD
Thema
20/20 Biolabs Inc. 20/20 Biolabs Inc.

20/20 Biolabs Inc.

AIDX
Rang in Aktien #33866
20/20 GeneSystems, Inc. operates as a clinical laboratory testing company... 20/20 GeneSystems, Inc. operates as a clinical laboratory testing company focused on cancer screening and viral testing services. The company provides multi-cancer early detection blood testing, including a test called OneTest, and offers viral testing services such as rapid COVID-19 test kits, including the Assure COVID-19 IgG/IgM rapid test. It operates the Clinical Lab Innovation Axcelerator (CLIAx), a shared laboratory facility that supports diagnostic test developers in bringing products to the U.S. market. The company also delivers its cancer screening algorithm technology through a software as a service (SaaS) platform in partnership with healthcare providers and supports diagnostic startups by offering access to shared laboratory space and resources. The company was founded in 2000 and is based in Gaithersburg, Maryland.
Aktienkurs
$0.5475
Zuletzt synchronisiert: 2026-08-14
Marktkapitalisierung
$6.71M
Veränderung (1 Tag)
5.57%
Veränderung (1 Jahr)
-
Land
US
Handel 20/20 Biolabs Inc. (AIDX)

Kategorie

Healthcare
P/S-Verhältnis für 20/20 Biolabs Inc. (AIDX)
P/S-Verhältnis zum 2026 TTM: 0
Laut den neuesten Finanzberichten und dem Aktienkurs von 20/20 Biolabs Inc. beträgt das aktuelle Kurs-Umsatz-Verhältnis (TTM) 0. Am Ende des Jahres 2026 lag das P/S-Verhältnis bei 0.
P/S-Verlauf für 20/20 Biolabs Inc. von 2026 bis 2026
P/S-Verhältnis zum Jahresende
Jahr P/S-Verhältnis ändert
Nicht genügend Daten für die angegebenen Daten.
P/S-Verhältnis für ähnliche Unternehmen oder Wettbewerber
Unternehmen P/S-Verhältnis P/S-Verhältnis-Differenz Land
HCA Healthcare, Inc. HCA Healthcare, Inc.
HCA Healthcare, Inc.
HCA.US
1.12 -
US
Fresenius SE & Co. KGaA Fresenius SE & Co. KGaA
Fresenius SE & Co. KGaA
FRE.DE
- -
DE
Dr. Sulaiman Al Habib Medical Services Group Company Dr. Sulaiman Al Habib Medical Services Group Company
Dr. Sulaiman Al Habib Medical Services Group Company
4013.SR
5.47 -
SA
Tenet Healthcare Corporation Tenet Healthcare Corporation
Tenet Healthcare Corporation
THC.US
0.99 -
US
IHH Healthcare Berhad IHH Healthcare Berhad
IHH Healthcare Berhad
5225.KL
- -
MY